We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.06B
1-Year Est. Return
24.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.68%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$846M
AUM Growth
+$67.3M
(+8.6%)
Cap. Flow
-$4.21M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
268
New
3
Increased
–
Reduced
2
Closed
3
Top Buys
| 1 |
Warner Bros
WBD
|
+$519K |
| 2 |
American International
AIG
|
+$503K |
| 3 |
Organon & Co
OGN
|
+$340K |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$3.72M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$552K |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$470K |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$463K |
| 5 |
Merck
MRK
|
+$368K |
Sector Composition
| 1 | Technology | 32.14% |
| 2 | Healthcare | 12.9% |
| 3 | Communication Services | 12.39% |
| 4 | Financials | 12.38% |
| 5 | Consumer Discretionary | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lam Research
LRCX
$401B
| $2.77M | 0.33% |
42,500
| – | – |
|
77
S&P Global
SPGI
$135B
| $2.75M | 0.32% |
6,695
| – | – |
|
78
Biogen
BIIB
$30.8B
| $2.74M | 0.32% |
7,921
| – | – |
|
79
Cardinal Health
CAH
$53.6B
| $2.65M | 0.31% |
45,552
| – | – |
|
80
HCA Healthcare
HCA
$85.6B
| $2.64M | 0.31% |
12,772
| – | – |
|
81
Norfolk Southern
NSC
$75.9B
| $2.6M | 0.31% |
9,796
| – | – |
|
82
Edwards Lifesciences
EW
$50.6B
| $2.59M | 0.31% |
24,984
| – | – |
|
83
Pfizer
PFE
$143B
| $2.5M | 0.29% |
63,742
| – | – |
|
84
Mondelez International
MDLZ
$78.8B
| $2.45M | 0.29% |
39,058
| – | – |
|
85
Eli Lilly
LLY
$1.04T
| $2.42M | 0.29% |
10,546
| – | – |
|
86
Eversource Energy
ES
$28.2B
| $2.41M | 0.28% |
29,994
| – | – |
|
87
State Street
STT
$51.4B
| $2.39M | 0.28% |
28,835
| – | – |
|
88
Trane Technologies
TT
$105B
| $2.38M | 0.28% |
12,904
| – | – |
|
89
CSX Corp
CSX
$94.6B
| $2.36M | 0.28% |
73,698
| – | – |
|
90
Automatic Data Processing
ADP
$103B
| $2.36M | 0.28% |
11,811
| – | – |
|
91
Marriott International
MAR
$97.9B
| $2.35M | 0.28% |
17,228
| – | – |
|
92
Qualcomm
QCOM
$180B
| $2.34M | 0.28% |
16,391
| – | – |
|
93
Broadcom
AVGO
$1.78T
| $2.33M | 0.28% |
48,910
| – | – |
|
94
Kimberly-Clark
KMB
$36.2B
| $2.28M | 0.27% |
16,889
| – | – |
|
95
Abbott
ABT
$172B
| $2.21M | 0.26% |
19,031
| – | – |
|
96
Wells Fargo
WFC
$267B
| $2.19M | 0.26% |
48,237
| – | – |
|
97
Advanced Micro Devices
AMD
$817B
| $2.18M | 0.26% |
23,249
| – | – |
|
98
Bunge Global
BG
$22.5B
| $2.12M | 0.25% |
27,064
| – | – |
|
|
BNY
99
Bank of New York Mellon
BNY
$110B
| $2.06M | 0.24% |
40,186
| – | – |
|
100
CME Group
CME
$89B
| $2.05M | 0.24% |
9,657
| – | – |
|
Similar funds
MWA
SFP
CA
WB
BL
RFM
MFS
ECM
Kintegral Advisory's Q2 2021 Portfolio in Review
As of Q2 2021, Kintegral Advisory held 268 positions worth $846M, up 8.6% from $779M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 2.2%. Kintegral Advisory opened 3 new positions and exited 3, leaving the 268-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Communication Services.
- Kintegral Advisory's largest Q2 2021 buy was Warner Bros: 14,974 shares worth $434K.
- Kintegral Advisory's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $3.72M.
- Kintegral Advisory fully exited Discovery, Inc. Series C Common Stock in Q2 2021, selling an estimated $552K.
- Kintegral Advisory's ten largest holdings make up 34% of its $846M portfolio in Q2 2021.
- Kintegral Advisory opened 3 new positions and closed 3 in Q2 2021.
- Kintegral Advisory's portfolio value rose 8.6% quarter-over-quarter to $846M.
Based on Kintegral Advisory's 13F filing for Q2 2021, filed 16 Aug 2021.